Sarah E. Kim
Lawyers
Filters
Upgrade Series G equity financing
We advised Upgrade in connection with the transaction
Oruka Therapeutics $180 million private placement
The PIPE included common stock and pre-funded warrants
GenFleet Therapeutics HK$1.82 billion IPO
We advised GenFleet on its IPO and HKEX listing
Baldwin Group $1.006 billion credit facilities financing
We advised the borrower on the refinancing and amendment
Strive Nasdaq listing and $450 million at-the-market offering
We advised Strive on its Nasdaq listing and offering
Webster Financial $350 million subordinated notes offering
We advised Webster Financial on the investment-grade offering
Prosus $12 billion program update and €750 million notes offering
The investment-grade notes are due 2035
Verisk $1.5 billion senior notes offering
We advised Verisk on the investment-grade notes offering
PetSmart $2.7 billion notes offering
The high-yield notes are due 2032 and 2033
Circle $1.5 billion follow-on offering
We advised Circle on its first follow-on offering as a listed company on NYSE